Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines ; day:15 ; month:5 ; year:2024 ; pages:1-14
Naunyn-Schmiedeberg's archives of pharmacology ; (15.5.2024), 1-14
- Creator
-
Zehra, Kanli
Banu, Aydin
Can, Erzik
Hülya, Cabadak
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00210-024-03145-0
- URN
-
urn:nbn:de:101:1-2407242107081.781142918111
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zehra, Kanli
- Banu, Aydin
- Can, Erzik
- Hülya, Cabadak
- SpringerLink (Online service)
Other Objects (12)
Capecitabine-Associated Terminal Ileitis
Photosensitive lichenoid skin reaction to capecitabine
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adherence Management for Cancer Patients on Capecitabine
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Oromandibular dystonia: a serious side effect of capecitabine
Hepatic steatosis secondary to capecitabine: a case report
Capecitabine-Related Fourth Nerve Palsy: A Case Report
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine in the treatment of metastatic renal cell carcinoma
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Capecitabine-Associated Terminal Ileitis
Photosensitive lichenoid skin reaction to capecitabine
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adherence Management for Cancer Patients on Capecitabine
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Oromandibular dystonia: a serious side effect of capecitabine
Hepatic steatosis secondary to capecitabine: a case report
Capecitabine-Related Fourth Nerve Palsy: A Case Report
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine in the treatment of metastatic renal cell carcinoma
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Capecitabine-Associated Terminal Ileitis
Photosensitive lichenoid skin reaction to capecitabine
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
Adherence Management for Cancer Patients on Capecitabine
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Oromandibular dystonia: a serious side effect of capecitabine
Hepatic steatosis secondary to capecitabine: a case report
Capecitabine-Related Fourth Nerve Palsy: A Case Report
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine in the treatment of metastatic renal cell carcinoma
Phase I pharmacological study of continuous chronomodulated capecitabine treatment